India supplies 60% of global vaccines and China controls 70% of API production. This article explains how these nations shape the generic drug market, their challenges, and the role of emerging economies like Vietnam and Cambodia in the global supply chain.
China and India dominate global pharmaceutical manufacturing, but their regulatory risks and FDA oversight differ sharply. India leads in compliance; China leads in scale. Here's how it affects drug safety and supply chains.